Plasma lipoprotein (a)[L p (a)] is a quantitative genetic trait with a very broad and skewed
distribution, which is largely controlled by genetic variants at the LPA locus on chromosome …

Abstract High lipoprotein (a)[Lp (a)] concentrations are one of the most important genetically
determined risk factors for cardiovascular disease. Lp (a) concentrations are an enigmatic …

Atherosclerosis is the narrowing of arteries due to the accumulation of macrophages
overloaded with lipids resulting in foam cell formation, and these events occur preferentially …

Several emerging plasma biomarkers may ultimately prove useful in risk stratification and
prognosis of cardiovascular disease. The clinical utility of these biomarkers will depend on …

Lipoprotein (a)[Lp (a)], is present only in humans, Old World nonhuman primates, and the
European hedgehog. Lp (a) has many properties in common with low-density lipoprotein …

OBJECTIVES This prospective population study was conducted to assess the role of
elevated lipoprotein (a)[Lp (a)] as a coronary risk factor. BACKGROUND The role of elevated …

Objectives: The purpose of this work was to determine the predictive value of oxidized
phospholipids (OxPLs) present on apolipoprotein B-100 particles (apoB) in carotid and …

Background—Elevated levels of oxidized phospholipids (OxPLs) on apolipoprotein B-100
particles (OxPL/apoB) are associated with cardiovascular disease and predict new …

Objectives: This study sought to assess whether an antisense oligonucleotide (ASO)
directed to apolipoprotein (a)[apo (a)] reduces apo (a) and lipoprotein (a)[Lp (a)] levels in …

Lipoprotein (a)[Lp (a)] is characterized by apolipoprotein (a)[apo (a)] covalently bound to
apolipoprotein B 100. It was described in human plasma by Berg et al. in 1963 and the gene …